Schumer has been candid about her health journey through the years, sharing in December 2025 that she lost 50 pounds as a way to survive her battle with Cushing syndrome
Retatrutide is a novel polypeptide being investigated for its multi-agonist properties, targeting the GLP-1, GIP, and glucagon receptors
In fact, Thymosin Beta-4 has been tested topically in clinical trials regarding its potential for skin and corneal healing [12]
Finally, its important to note that making dietary changes to boost GLP-1 release is likely not comparable to the effectiveness of GLP-1 receptor agonist medications like semaglutide
Furthermore, NaB promoted GLP-1-mediated upregulated IRS-1 expression and phosphorylation of AMPK and ACC (Fig
For example, mean standard deviation glycated hemoglobin levels were 8.7 1.5% in LEADER and 7.7 1.3% in ELIXA